psoriasis trial enters final stage... Solbec Pharmaceuticals Ltd...

psoriasis trial enters final stage... Solbec Pharmaceuticals Ltd (ASX:SBP) today announced
the successful completion of the first two stages of the Phase I clinical trial of its lead compound,
CoramsineTM (SBP002), for the treatment of psoriasis. The company has entered the third and
final stage of the clinical trial which involves the testing of CoramsineTM on patients with
psoriasis. Importantly for Solbec, the trial will monitor how well the psoriasis responds to treatment
as well as any unwanted outcomes. Results should be out early 2005. Cancer results shouldn't be too far behind.